Pro Medicus Gestion

Gestion contrôle des critères 4/4

Le PDG Pro Medicus est Sam Hupert, nommé en Jan1983, a un mandat de 41.83 ans. La rémunération annuelle totale est A$ 965.22K, composée du salaire de 95.5% et des bonus 4.5%, y compris les actions et options de la société. détient directement 24.06% des actions de la société, d'une valeur de A$ 5.57B. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 11 ans et 8.5 ans.

Informations clés

Sam Hupert

Directeur général

AU$965.2k

Rémunération totale

Pourcentage du salaire du PDG	95.5%
Durée du mandat du directeur général	41.8yrs
Propriété du PDG	24.1%
Durée moyenne d'occupation des postes de direction	11yrs
Durée moyenne du mandat des membres du conseil d'administration	8.5yrs

Mises à jour récentes de la gestion

Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being

Nov 18

Recent updates

Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being

Nov 18

Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention

Aug 12

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Jul 08

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

May 09

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Apr 02

Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital

Jan 25

We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease

Dec 13

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Oct 26

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Sep 14

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Jul 06

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Jun 15

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Mar 16

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Feb 23

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Oct 26

Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively

Aug 13

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Jul 26

Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency

May 07

Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 15

This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)

Feb 20

Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Feb 18

Is Pro Medicus (ASX:PME) The Next Multi-Bagger?

Feb 01

How Much Did Pro Medicus' (ASX:PME) CEO Pocket Last Year?

Jan 12

Should You Be Adding Pro Medicus (ASX:PME) To Your Watchlist Today?

Dec 28

Pro Medicus (ASX:PME) Has Rewarded Shareholders With An Exceptional 825% Total Return On Their Investment

Dec 11

Is Pro Medicus Limited's (ASX:PME) Shareholder Ownership Skewed Towards Insiders?

Nov 26

Pro Medicus's (ASX:PME) Earnings Are Growing But Is There More To The Story?

Aug 09

What Kind Of Shareholders Hold The Majority In Pro Medicus Limited's (ASX:PME) Shares?

Aug 09

Does Pro Medicus (ASX:PME) Have The DNA Of A Multi-Bagger?

Jul 21

How Much Are Pro Medicus Limited (ASX:PME) Insiders Taking Off The Table?

Jul 03

Analyse de la rémunération des PDG

Comment la rémunération de Sam Hupert a-t-elle évolué par rapport aux bénéfices de Pro Medicus?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	AU$965k	AU$921k	AU$83m
Mar 31 2024	n/a	n/a	AU$76m
Dec 31 2023	n/a	n/a	AU$70m
Sep 30 2023	n/a	n/a	AU$65m
Jun 30 2023	AU$1m	AU$723k	AU$61m
Mar 31 2023	n/a	n/a	AU$56m
Dec 31 2022	n/a	n/a	AU$51m
Sep 30 2022	n/a	n/a	AU$48m
Jun 30 2022	AU$510k	AU$475k	AU$44m
Mar 31 2022	n/a	n/a	AU$41m
Dec 31 2021	n/a	n/a	AU$38m
Sep 30 2021	n/a	n/a	AU$34m
Jun 30 2021	AU$508k	AU$475k	AU$31m
Mar 31 2021	n/a	n/a	AU$28m
Dec 31 2020	n/a	n/a	AU$25m
Sep 30 2020	n/a	n/a	AU$24m
Jun 30 2020	AU$508k	AU$475k	AU$23m
Mar 31 2020	n/a	n/a	AU$23m
Dec 31 2019	n/a	n/a	AU$22m
Sep 30 2019	n/a	n/a	AU$21m
Jun 30 2019	AU$508k	AU$475k	AU$19m
Mar 31 2019	n/a	n/a	AU$17m
Dec 31 2018	n/a	n/a	AU$16m
Sep 30 2018	n/a	n/a	AU$13m
Jun 30 2018	AU$518k	AU$475k	AU$10m

Rémunération vs marché: La rémunération totale de Sam ($USD 627.26K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché Australian ($USD 4.41M ).

Rémunération et revenus: La rémunération de Sam a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Sam Hupert

41.8yrs

Titularisation

AU$965,221

Compensation

Dr. Sam Aaron Hupert, M.B.B.S., MD has been the Chief Executive Officer and Managing Director at Pro Medicus Limited (alternate name: PRO Medicus Ltd.) since October 2010. Dr. Hupert serves as Member of Ad...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Sam Hupert	Co-Founder	41.8yrs	AU$965.22k	24.06% A$ 5.6b
Anthony Hall	Co-Founder	41.8yrs	AU$373.26k	24.03% A$ 5.6b
Clayton Hatch	Chief Financial Officer	12.3yrs	AU$500.77k	0.034% A$ 7.9m
Malte Westerhoff	GM of Europe & Global CTO	no data	AU$1.59m	0.099% A$ 22.9m
Brad Levin	GM of North America & Global Head of Marketing	no data	AU$401.25k	pas de données
Sharni Redenbach	People & Culture Director	2.3yrs	pas de données	pas de données
Sean Lambright	Global Head of Sales - Visage Imaging Inc	9.3yrs	AU$1.21m	0.17% A$ 39.5m
Teresa Gschwind	Global Head of Customer Service of Visage Imaging Inc.	no data	pas de données	pas de données
Danny English	Financial Controller & Company Secretary	9.7yrs	pas de données	pas de données

11.0yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe dirigeante de PME est chevronnée et expérimentée (11 années d'ancienneté moyenne).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Sam Hupert	Co-Founder	41.8yrs	AU$965.22k	24.06% A$ 5.6b
Anthony Hall	Co-Founder	41.8yrs	AU$373.26k	24.03% A$ 5.6b
Alice Joans Williams	Independent Non-Executive Director	3.2yrs	AU$125.00k	0.0020% A$ 456.5k
Leigh Farrell	Independent Non-Executive Director	7.2yrs	AU$125.00k	0.0041% A$ 940.8k
Peter Kempen	Chairman	16.7yrs	AU$250.00k	0.30% A$ 69.7m
Deena Shiff	Independent Non-Executive Director	4.3yrs	AU$125.00k	0.0018% A$ 426.4k
Anthony Glenning	Independent Non-Executive Director	8.5yrs	AU$125.00k	0.0091% A$ 2.1m

8.5yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: Les membres du conseil d'administration de PME sont considérés comme expérimentés (ancienneté moyenne 8.5 ans).

Pro Medicus Gestion

Gestion contrôle des critères 4/4

Informations clés

Mises à jour récentes de la gestion

Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being

Pro Medicus Limited, Annual General Meeting, Nov 25, 2024

Co-Founder recently sold AU$88m worth of stock

Pro Medicus Limited, Annual General Meeting, Nov 20, 2023

Insufficient new directors

Chairman recently sold AU$3.1m worth of stock

Recent updates

Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being

With EPS Growth And More, Pro Medicus (ASX:PME) Makes An Interesting Case

Price target increased by 8.6% to AU$139

Pro Medicus Limited, Annual General Meeting, Nov 25, 2024

Upcoming dividend of AU$0.22 per share

Final dividend of AU$0.22 announced

New major risk - Earnings quality

Price target increased by 15% to AU$123

Full year 2024 earnings: EPS exceeds analyst expectations

Pro Medicus Limited to Report Fiscal Year 2024 Results on Aug 14, 2024

Do Pro Medicus' (ASX:PME) Earnings Warrant Your Attention?

Upcoming dividend of AU$0.18 per share

First half dividend of AU$0.18 announced

First half 2024 earnings: EPS misses analyst expectations

Pro Medicus Limited to Report First Half, 2024 Results on Feb 15, 2024

Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today

Price target increased by 8.5% to AU$78.14

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Co-Founder recently sold AU$88m worth of stock

New minor risk - Insider selling

Pro Medicus Limited, Annual General Meeting, Nov 20, 2023

Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors

Insufficient new directors

Upcoming dividend of AU$0.17 per share at 0.5% yield

Price target increased by 7.4% to AU$67.29

New major risk - Earnings quality

Price target increased by 7.6% to AU$65.64

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention

Pro Medicus Limited to Report Fiscal Year 2023 Final Results on Aug 15, 2023

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Chairman recently sold AU$3.1m worth of stock

Upcoming dividend of AU$0.13 per share at 0.4% yield

First half 2023 earnings: EPS in line with analyst expectations despite revenue beat

Pro Medicus Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 24, 2023

Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital

Pro Medicus Limited to Report First Half, 2023 Results on Feb 15, 2023

We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Pro Medicus Limited, Annual General Meeting, Nov 21, 2022

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Upcoming dividend of AU$0.12 per share

Full year 2022 earnings: EPS misses analyst expectations

Pro Medicus Limited Announces Fully Franked Ordinary Dividend for the Period of Twelve Months Ended June 30, 2022, Payable on September 30, 2022

Pro Medicus Limited to Report Q4, 2022 Results on Aug 18, 2022

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Upcoming dividend of AU$0.10 per share

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

First half 2022 earnings: EPS and revenues exceed analyst expectations

Pro Medicus Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 25, 2022

Pro Medicus Limited to Report First Half, 2022 Results on Feb 16, 2022

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Upcoming dividend of AU$0.08 per share

Price target increased to AU$52.25

Full year 2021 earnings released: EPS AU$0.30 (vs AU$0.22 in FY 2020)

Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency

Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Co-Founder recently sold AU$46m worth of stock

This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)

First half 2021 earnings released: EPS AU$0.13 (vs AU$0.12 in 1H 2020)

Revenue and earnings miss expectations

Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Price target raised to AU$40.82